April 6, 2026 – Coin Craziness

Newsletters

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

2 min read

Posted on April 6, 2026

by Coin Craziness

By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…

Newsletters

2 min read

Posted on April 6, 2026

by Coin Craziness

By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…